Cancer Clinical Trial - Agenus C-800-01

Cancer

Status:

Open

ClinicalTrials.gov:

CONDITION(S): Ovarian Cancer -TRIAL:Agenus C-800-01.

This study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, PK, and PD profiles of a novel Fc-engineered IgG1 anti-CTLA-4 human monoclonal antibody (AGEN1181), and to assess the maximum tolerated dose (MTD) in subjects with advanced solid tumors. This study will also determine the RP2D of AGEN1181 monotherapy.

Drug

AGEN1181

Trial Type

Interventional

Phase

Phase 1

Condition

Ovarian cancer

Keywords